Expert Overviews

Watch experts summarising some of the most interesting presentations from this year’s Annual Meeting.

In this overview:

Challenges in insulin therapy

307

Improving efficacy and adherence

1326

ADA/EASD consensus on management of hyperglycaemia in T2D

Ask the Expert

Watch the video which answers some of the questions you submitted.

Watch the video

In this overview:

Dulaglutide in youth with type 2 diabetes: results of the AWARD-PEDS randomised, placebo-controlled trial

484

Ly3437943 (LY) a novel triple GIP/GLP-1/glucagon receptor agonist, provides glucose lowering and weight loss in patients with type 2 diabetes after 12 weeks of treatment

Ask the Expert

Watch the video which answers some of the questions you submitted.

Watch the video

In this overview:

386

Post approval, observational, concurrent study to assess clinical effectiveness and safety of dapaglifozin in diabetic kidney disease: INTENSE - DAPA study

556

Effect of treatment with semaglutide, empaglifozin and the combination on kidney function in type 2 diabetes: impact of oxygenation and perfusion

744

Design of the Combination effect of Finerenone and Empaglifozin in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

866

Management of hyperglycemia in type 2 diabetes: ADA/EASD consensus Report 2022

1416

Development in eGFR trajectories in people with diabetic nephropathy